11606
Jumina et al. / Tetrahedron 64 (2008) 11603–11610
(13,900). nmax 1710, 1630, 1600, 1560, 1230, 1210, 1150, 1000 cmꢁ1
1H NMR spectrum (300 MHz, CDCl3):
3.79 (6H, s, OMe), 5.35 (2H,
.
C25H17Br2NO3 requires C, 55.7; H, 3.2; N, 2.6%.) lmax 210 nm (3
d
20,200 cmꢁ1 Mꢁ1), 221 (15,700), 267 (10,500), 281 (9200), 365
s, CH2), 6.19 (1H, d, J 1.8 Hz, H5), 6.27 (1H, d, J 1.8 Hz, H7), 6.85 (1H, s,
(10,100). nmax 1630, 1590, 1520, 1350, 1230, 1180, 1160, 980 cmꢁ1. 1H
NMR spectrum (300 MHz, DMSO-d6): d 4.04 and 4.19 (6H, 2s, OMe),
H2), 7.46 (4H, s, ArH), 7.65 and 7.84 (4H, 2d, J 8.2 Hz, ArH). 13C NMR
spectrum (75 MHz, CDCl3):
d
52.3 (CH2), 55.1 and 55.6 (OMe), 85.3
6.65 (1H, s, H7), 7.61, 7.81 and 7.91 (8H, m, ArH), 7.66 (1H, s, H5),
8.22 (1H, s, H2). The compound was not sufficiently soluble to
obtain a 13C NMR spectrum. Mass spectrum: m/z 542 (Mþ1, 81Br,
13%), 541 (M, 81Br, 51), 540 (Mþ1, 79,81Br, 33), 539 (M, 79,81Br, 73),
537 (M, 79Br, 30), 188 (22), 185 (94), 183 (54), 182 (80), 158 (98), 155
(100), 76 (58), 75 (78), 69 (34), 55 (22), 43 (40).
When the formylindole 5 (0.11 g, 0.20 mmol) was dissolved in
dimethylformamide (4 mL), then reacted with a saturated solution
of sodium hydroxide in methanol according to the method of
preparation of compound 6, the pyrroloindole 7 was obtained as
a bright yellow solid (69 mg, 64%), mp 251–253 ꢀC.
(C5), 92.4 (C7),117.7,119.7, 125.0, 133.3, 134.7,139.2, 155.0,158.0 and
192.0 (ArC), 125.0 (C2), 129.5, 130.6, 131.1 and 132.3 (ArCH), 209.6
(CO). Mass spectrum: m/z 531(M, 81Br, 19%), 530 (Mþ1, 79,81Br, 18),
529 (M, 79,81Br, 58), 528 (Mþ1, 79Br, 11), 527 (M, 79Br, 23), 346 (87),
345 (42), 344 (100), 207 (32), 185 (37), 185 (39), 156 (62), 155 (65),
76 (68), 75 (58), 69 (53), 43 (47).
4.4. 4,6-Dimethoxy-1-phenacyl-3-phenylindole-7-
carbaldehyde (4)
A cooled solution of phosphoryl chloride (0.19 mL, 2.03 mmol)
in dry dimethylformamide (1.0 mL) was added dropwise to a cooled
solution of the phenacylindole 2 (0.5 g, 1.35 mmol) in dry dime-
thylformamide (4 mL). The mixture was stirred at 0 ꢀC for 15 min,
then warmed at 80 ꢀC for another 30 min. Cold water (10 mL) was
added, followed by excess 2 M sodium hydroxide solution until the
mixture was strongly basic. The suspension was stirred at room
temperature overnight, the resulting precipitate was filtered,
washed with water and dried. The resulting solid was flash chro-
matographed with dichloromethane elution and yielded the for-
mylindole 4 as a white solid (0.37 g, 69%), mp 208–211 ꢀC. (Found:
C, 75.4; H, 5.3; N, 3.5. C25H21NO4 requires C, 75.2; H, 5.3; N, 3.5%.)
4.6. 4-Benzoyl-6,8-dimethoxy-1-phenylpyrrolo[3,2,1-hi]-
indole (6)
Excess saturated solution of sodium hydroxide in methanol was
added dropwise to a solution of formylindole 4 (0.1 g, 0.25 mmol)
in dimethylformamide (4 mL) until the mixture was strongly basic.
The mixture was stirred at room temperature for 30 min, the
resulting yellow precipitate was filtered, washed with water and
dried. Thin layer chromatography and elution with dichloro-
methane gave the pyrroloindole 6 as a yellow solid (60 mg, 63%),
mp 160–163 ꢀC. (Found: C, 78.5; H, 5.3; N, 3.7. C25H19NO3 requires
lmax 214 nm (
(5400), 353 (5500). nmax 1700, 1650, 1590, 1550, 1270, 1220, 1060,
1030, 610 cmꢁ1 1H NMR spectrum (300 MHz, CDCl3):
3.90 and
3
5000 cmꢁ1 Mꢁ1), 252 (6500), 268 (6800), 340
C, 78.7; H, 5.0; N, 3.7%.) lmax 207 nm (
(25,000), 255 (18,700), 277 (10,800), 362 (22,200). nmax 1720, 1650,
1620, 1590, 1340, 1230, 1200 cmꢁ1 1H NMR spectrum (300 MHz,
CDCl3): 4.03 and 4.17 (6H, 2s, OMe), 6.48 (1H, s, H7), 7.32, 7.43,
7.53, 7.60 and 7.97 (10H, m, ArH), 7.39 (1H, s, H5), 8.15 (1H, s, H2).
13C NMR spectrum (75 MHz, CDCl3):
56.2 and 57.5 (OMe), 94.9
3
43,600 cmꢁ1 Mꢁ1), 220
.
d
.
3.98 (6H, 2s, OMe), 6.18 (2H, s, CH2), 6.28 (1H, s, H5), 6.84 (1H, s,
d
H2), 7.31, 7.55 and 8.05 (10H, m, ArH), 10.30 (1H, s, CHO). 13C NMR
spectrum (75 MHz, DMSO-d6):
d 55.3 and 56.8 (OMe), 58.0 (CH2),
d
87.8, 125.5, 127.2, 127.6, 128.5, 129.1, 129.8 and 133.0 (ArCH), 106.0,
112.0, 117.7, 134.7, 135.1, 136.2, 160.5 and 164. 4 (ArC), 186.8 (CHO),
193.2 (CO). Mass spectrum: m/z 400 (Mþ1, 12%), 399 (M, 51), 295
(16), 294 (100), 279 (32), 264 (17), 236 (23), 208 (13), 105 (21), 77
(31).
(C7), 119.1 (C5), 120.3 (C2), 126.5, 127.8, 128.3, 128.4, 128.8 and 131.9
(ArCH), 102.4, 102.9, 127.0, 132.8, 134.7, 138.6, 141.5, 158.6 and 158.9
(ArC),186.7 (CO). Mass spectrum: m/z 382 (Mþ1, 27%), 381 (M,100),
105 (81), 77 (53).
4.5. 1-(40-Bromophenacyl)-3-(40-bromophenyl)-4,6-dimeth-
oxyindole-7-carbaldehyde (5) and 4-(40-bromobenzoyl)-1-
(40-bromophenyl)-6,8-dimethoxypyrrolo[3,2,1-hi]indole (7)
4.7. Ethyl 3(40-bromophenyl)-4,6-dimethoxyindol-
1-ylacetate (12)
A mixture of powdered potassium hydroxide (0.12 g, 2.1 mmol)
and dimethylsulfoxide (10 mL) was stirred at room temperature for
10 min, indole 8 (0.50 g, 2.0 mmol) was added, and the mixture was
Indole 3 (1.61 g, 3.05 mmol) was dissolved in dry dime-
thylformamide (15 mL), then reacted with a solution of phosphoryl
chloride (0.42 mL, 4.58 mmol) in dry dimethylformamide (1 mL)
according to the method of preparation of compound 4. The
resulting brown precipitate was filtered, washed with water and
dried. Flash chromatography and elution with dichloromethane
gave two products. The first product was the formylindole 5 as
a pale-yellow solid (0.98 g, 58%), mp 210–212 ꢀC. (Found: C, 54.2; H,
3.6; N, 2.2. C25H19Br2NO4 requires C, 53.9; H, 3.4; N, 2.5%.) lmax
stirred for another 30 min. Ethyl
a-bromoacetate (0.4 mL,
3.6 mmol) was added dropwise, and the mixture was stirred
overnight. The resulting brown-yellow mixture was diluted with
water (70 mL), extracted with dichloromethane (3ꢂ60 mL) and the
combined organic layers were washed with water, dried over
magnesium sulfate and evaporated to give a brown oil. Flash
chromatography and elution with dichloromethane afforded the
ethyl indolylacetate 12 as an off-white solid (0.63 g, 78%), mp 104–
105 ꢀC. (Found: C, 57.1; H, 4.6; N, 3.1. C20H20BrNO4 requires C, 57.4;
213 nm (
nmax 1720, 1670, 1590, 1570, 1270, 1230, 1170 cmꢁ1. 1H NMR spec-
trum (300 MHz, CDCl3): 3.88 and 3.95 (6H, 2s, OMe), 6.07 (2H, s,
CH2), 6.25 (1H, s, H5), 6.79 (1H, s, H2), 7.42 and 7.77 (8H, m, ArH),
10.24 (1H, s, CHO). 13C NMR spectrum (75 MHz, DMSO-d6):
55.8
3
14,300 cmꢁ1 Mꢁ1), 260 (19,000), 336 (6200), 351 (6200).
d
H, 4.8; N, 3.4%.) lmax 208 nm (
(25,400), 284 (13,500), 299 (12,100). nmax 1740, 1620, 1280, 1220,
1200, 1160, 790 cmꢁ1. 1H NMR spectrum (300 MHz, CDCl3):
1.28
3
29,800 cmꢁ1 Mꢁ1), 223 (31,000), 231
d
d
and 57.3 (OMe), 58.1 (CH2), 88.7, 129.9, 130.3, 130.5, 131.3 and 131.9
(ArCH), 106.0, 111.8, 116.2, 119.2, 127.6, 133.8, 134.5, 136.2, 160.6 and
164.6 (ArC), 187.0 (CHO), 192.9 (CO). Mass spectrum: m/z 559 (M,
81Br, 16%), 558 (Mþ1, 79,81Br, 18), 557 (M, 79,81Br, 32), 556 (Mþ1,
79Br, 15), 555 (M, 79Br, 22), 375 (20), 374 (100), 373 (14), 372 (84),
359 (22), 357 (21), 314 (18), 220 (29), 207 (34), 185 (43), 182 (42),
157 (89), 155 (88), 76 (72), 75 (58), 50 (36).
(3H, t, J 7.1 Hz, CH2CH3), 3.80 and 3.86 (6H, 2s, OMe), 4.24 (2H, q, J
7.1 Hz, CH2CH3), 4.76 (2H, s, CH2), 6.28 (1H, d, J 2.0 Hz, H5), 6.31 (1H,
d, J 2.0 Hz, H7), 6.91 (1H, s, H2), 7.47 (4H, s, ArH). 13C NMR spectrum
(75 MHz, CDCl3):
d 14.2 (CH2CH3), 48.1 (CH2), 55.2 and 55.7 (OMe),
61.8 (CH2CH3), 85.2 (C5), 92.5 (C7), 124.9 (C2), 110.7, 117.7, 119.7,
134.8, 139.0, 155.0 and 158.0 (ArC), 130.6 and 131.1 (ArCH), 168.3
(CO). Mass spectrum: m/z 419 (M, 81Br, 13%), 417 (M, 79Br, 15), 185
(93), 183 (100), 157 (29), 155 (31), 76 (37), 75 (32), 69 (39), 57 (41),
55 (36).
The second product was the pyrroloindole 7 as a bright yellow
solid (0.31 g, 20%), mp 250–253 ꢀC. (Found: C, 55.8; H, 3.3; N, 2.4.